Clinical trial
An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar…
NCT00221416 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00221416 |
|---|---|
| Title | An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder |
| Official title | An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | Children's Hospital Medical Center, Cincinnati Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 30 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 27, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: